Hainan Huluwa Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 35.2% in First Quarter of 2023

Hainan Huluwa Pharmaceutical Group Co.,Ltd. (海南葫芦娃药业集团股份有限公司) (605199.SH) reported a net profit of 40.4 million yuan in the first quarter of 2023, up 35.2% year-on-year.

Meanwhile, the company posted 527.3 million yuan in revenue, up 32.1% year-on-year.

At the end of the reporting period, it had 2.4 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 55.1%.